Small heat shock protein 20 (Hsp20) facilitates nuclear import of protein kinase D 1 (PKD1) during cardiac hypertrophy

Cell Communication and Signaling

Volumn 13, Issue 1, 2015, Pages

  Sin, Yuan Yan ^a   Martin, Tamara P ^a   Wills, Lauren ^a   Currie, Susan ^b   Baillie, George S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Cardiac hypertrophy; Hsp20; Peptide array; PKD1

Indexed keywords

GLYCYLALANYLALANYLVALYLALANYLISOLEUCYLLYSYLISOLEUCYLISOLEUCYLALANYLLYSYLLEUCYLARGINYLPHENYLALANYLPROLYLTHRONYLLYSYLGLUTAMINYLGLUTAMYLSERYLGLUTAMINYLLEUCYLARGINYLASPARAGINYLGLUTAMIC ACID; GLYCYLARGINYLASPARTYLVALYLALANYLISOLEUCYLLYSYLISOLEUCYLISOLEUCYLASPARTYLLYSYLLEUCYLARGINYLPHENYLALANYLPROLYLTHREONYLLYSYLGLUTAMINYLGLUTAMYLSERYLGLUTAMINYLLEUCYLARGINYLASPARAGINYLGLUTAMIC ACID; HEAT SHOCK PROTEIN 20; PEPTIDE DERIVATIVE; PROTEIN KINASE; PROTEIN KINASE D 1; UNCLASSIFIED DRUG; HSP20 PROTEIN, RAT; MULTIPROTEIN COMPLEX; MUSCLE PROTEIN; PROTEIN KINASE C; PROTEIN KINASE D;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CATALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; FETAL GENE; GENE; GENE EXPRESSION; HEART ATRIUM REMODELING; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; MUSCLE CELL; NONHUMAN; NUCLEAR IMPORT; NUCLEAR TRANSLOCATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRESS; ACTIVE TRANSPORT; ANIMAL; CARDIOMEGALY; CELL NUCLEUS; METABOLISM; PATHOLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BINDING SITES; CARDIOMEGALY; CELL NUCLEUS; HSP20 HEAT-SHOCK PROTEINS; MULTIPROTEIN COMPLEXES; MUSCLE PROTEINS; PROTEIN KINASE C; RATS; SIGNAL TRANSDUCTION;

EID: 84928748637     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-015-0094-x     Document Type: Article

References (31)

1. Dirkx E, da Costa Martins PA, De Windt LJ. Regulation of fetal gene expression in heart failure. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2013;1832:2414-24.
2. Rozengurt E. Protein kinase D signaling: multiple biological functions in health and disease. Physiology. 2011;26:23-33.
3. De Arcangelis V, Liu R, Soto D, Xiang Y. Differential association of phosphodiesterase 4D isoforms with β2-adrenoceptor in cardiac myocytes. J Biol Chem. 2009;284:33824-32.
4. Wang QJ. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci. 2006;27:317-23.
5. Rey O, Sinnett-Smith J, Zhukova E, Rozengurt E. Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J Biol Chem. 2001;276:49228-35.
6. Haworth RS, Cuello F, Herron TJ, Franzen G, Kentish JC, Gautel M, et al. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res. 2004;95:1091-9.
7. Cuello F, Bardswell SC, Haworth RS, Yin X, Lutz S, Wieland T, et al. Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ Res. 2007;100:864-73.
8. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol. 2004;24:8374-85.
9. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, et al. The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci. 2009;106:2342-7.
10. McKinsey TA, Zhang CL, Olson EN. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol. 2001;21:6312-21.
11. Fielitz J, Kim M-S, Shelton JM, Qi X, Hill JA, Richardson JA, et al. Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci. 2008;105:3059-63.
12. Martin T, Currie S, Baillie GS. The cardioprotective role of small heat-shock protein 20. Biochem Soc Trans. 2014;42:270-3.
13. Fan G-C, Chu G, Kranias EG. Hsp20 and its cardioprotection. Trends Cardiovascular Med. 2005;15:138-41.
14. Frank R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J Immunol Methods. 2002;267:13-26.
15. Sin YY, Edwards HV, Li X, Day JP, Christian F, Dunlop AJ, et al. Disruption of the cyclic AMP phosphodiesterase-4 (PDE4) - HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes. J Mol Cell Cardiol. 2011;50:872-83.
16. Smith KJ, Baillie GS, Hyde EI, Li X, Houslay TM, McCahill A, et al. 1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1. Cell Signal. 2007;19:2612-24.
17. Berthouze-Duquesnes M, Lucas A, Sauliere A, Sin YY, Laurent AC, Gales C, et al. Specific interactions between Epac1, beta-arrestin2 and PDE4D5 regulate beta-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling. Cell Signal. 2013;25:970-80.
18. Rampersad SN, Ovens JD, Huston E, Umana MB, Wilson LS, Netherton SJ, et al. Cyclic AMP phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a vascular endothelial cadherin (VE-Cad)-based signaling complex and controls cAMP-mediated vascular permeability. J Biol Chem. 2010;285:33614-22.
19. Wilson LS, Baillie GS, Pritchard LM, Umana B, Terrin A, Zaccolo M, et al. A phosphodiesterase 3B-based signaling complex integrates exchange protein activated by cAMP 1 and phosphatidylinositol 3-kinase signals in human arterial endothelial cells. J Biol Chem. 2011;286:16285-96.
20. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45-79.
21. Van Lint J, Rykx A, Maeda Y, Vantus T, Sturany S, Malhotra V, et al. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol. 2002;12:193-200.
22. Carnegie GK, Soughayer J, Smith FD, Pedroja BS, Zhang F, Diviani D, et al. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell. 2008;32:169-79.
23. Edwards HV, Scott JD, Baillie GS. The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Ser (16). Biochem J. 2012;446:437-43.
24. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol. 2004;24:8374-85.
25. Rey O, Sinnett-Smith J, Zhukova E, Rozengurt E. Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J Biol Chem. 2001;276:49228-35.
26. Fielitz J, Kim MS, Shelton JM, Qi X, Hill JA, Richardson JA, et al. Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci U S A. 2008;105:3059-63.
27. McKinsey TA. Derepression of pathological cardiac genes by members of the CaM kinase superfamily. Cardiovasc Res. 2007;73:667-77.
28. Geng J, Zhao Z, Kang W, Wang W, Zhang Y, Zhiming GE. Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats. Pharmacol Res. 2010;61:40-7.
29. Martin TP, Robinson E, Harvey AP, MacDonald M, Grieve DJ, Paul A, et al. Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice. Exp Physiol. 2012;97:822-32.
30. Li X, Baillie GS, Houslay MD. Mdm2 Directs the Ubiquitination of β-Arrestin-sequestered cAMP Phosphodiesterase-4D5. J Biol Chem. 2009;284:16170-82.
31. Bolger GB, Baillie GS, Li X, Lynch MJ, Herzyk P, Mohamed A, et al. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, β-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem J. 2006;398:23-36.